The Leading Resource for Consumer Healthcare Industry Education
About
Didn't get a chance to attend a few of last year's webinars? Take a look through CHPA Academy’s new Course Catalog which highlights all of our 2021 educational content!
CHPA has launched a new Learning Management System to make more programming available than ever before with ease. CHPA Academy is here to help members find connections and solutions, and features e-learning opportunities covering hot topics from the convenience of your computer or mobile device. Be sure to bookmark CHPA Academy and check back often for upcoming webinars and courses.
Academy Mission
To deliver convenient, high-quality industry education using a variety of media that will help CHPA members solve their toughest issues with optimal efficiency.
CHPA Academy topics include but are not limited to:
- Regulatory Affairs
- Government Affairs
- Sales
- Marketing
- Supply Chain
- Operations
- Quality
- Diversity, Equality, and Inclusion
- Executive Leadership
- Women in Consumer Healthcare
Interested in hosting a webinar with the CHPA Academy? Learn more here.
Important Notice for In-Person Attendees Below
January 3, 2022
CHPA is monitoring local and federal COVID guidelines so that we can safely meet in person. Updates will be provided on this website and in CHPA member communications. Proof of vaccination will be required and CHPA requests that all vaccinations are up to date.
Are you brand new to the Consumer Healthcare Industry and want to understand how the industry works? An industry professional looking for a refresher on the basics of Consumer Healthcare? A service provider who wants to better understand the Consumer Healthcare industry to effectively work with your clients?
CHPA’s Consumer Healthcare 101 (CH101) will equip you with the facts and tools you need to better understand the Consumer Healthcare industry in order to succeed. Whether you are brand new to the industry or interested in going “back to basics”, this in-person course will cover:
- The State of the Industry: Commercial Update 2021
- FDA Oversight of Nonprescription Drug Products
- OTC Drug Labeling Regulations
- OTC Monograph Reform Update
- Rx-to-OTC Switch
- Advertising 101
- Medical Devices
- Cosmetics & Dietary Supplements
- Manufacturing Quality Products
Program and Agenda
Tuesday, April 5
| Time | Event |
|---|---|
| 9:00-9:15 a.m. | Welcome and Overview |
| 9:15-11:15 a.m. |
The State of the Industry: Commercial Update 2021 IRI will outline the sales size, key brands, manufacturers & marketers, retailers, consumer behavior and key trends for the industry in 2021. OTCs as well as supplements will be covered. Speakers: Lisa Buono, Healthcare & Client Insights Principal, IRI Katie McNichol, Principal, IRI |
| 11:15-11:30 a.m. | AM Refreshment Break |
| 11:30 a.m.-12:30 p.m. |
FDA Oversight of Nonprescription Drug Products (Part 1) A discussion of FDA as the industry’s leading regulator will include an overview of FDA’s structure and the regulatory framework for our products. Speaker: Doug Bierer, President, Douglas Bierer Consulting |
| 12:30-1:30 p.m. | Lunch and Networking |
| 1:30-2:30 p.m. | FDA Oversight of Nonprescription Drug Products (Part 2) |
| 2:30-3:15 p.m. |
OTC Drug Labeling Regulations The presentation will cover OTC Drug labeling requirements per 21 CFR 201.66. The importance of drug monographs will also be covered as well as some things that may change under the new OTC Drug Safety, Innovation & Reform Act. Speaker: Norma Skolnik, EAS Consulting Group |
| 3:15-3:30 p.m. | PM Refreshment Break |
| 3:30-4:00 p.m. |
OTC Monograph Reform Update On March 27, 2020, Congress included landmark legislation to reform the OTC Monograph system in the COVID-19 response bill, the CARES Act. In this session, attendees will learn why reform was necessary, the key elements of policy reform covered by the legislation and FDA goals letter and how user fees will be assessed and fund reform activities at FDA. Speakers: Marcia Howard, Vice President, Regulatory & Scientific Affairs, CHPA Jay Sirois, Vice President, Research & Scientific Affairs, CHPA |
| 4:00-5:30 p.m. |
Rx to OTC Switch An introduction to the commercial, scientific and regulatory considerations and challenges when converting a prescription drug to a consumer product for self-care. Speaker: Ed Hemwall, Principal, Edwin Hemwall LLC |
| 5:30-6:30 p.m. | Networking Reception |
Wednesday, April 6
| Time | Event |
|---|---|
| 7:00-8:00 a.m. | Breakfast and Networking |
| 8:00-8:45 a.m. |
Medical Devices Overview of Medical Devices Speaker: Evan Phelps, Amin Talati |
| 8:45-9:45 a.m. |
Advertising 101 Overview of Advertising law governing consumer health products. Speaker: Raqiyyah Pippins, Counsel, Arnold & Porter |
| 9:45-10:00 a.m. | AM Refreshment Break |
| 10:00-10:30 a.m. |
Cosmetics & Dietary Supplements An overview of the FDA regulations related to safety, labeling, manufacturing and claims for cosmetics and dietary supplements. Speaker: Jay Sirois, Vice President, Research & Scientific Affairs, CHPA |
| 10:30-11:15 a.m. |
Manufacturing Quality Products Regulatory requirements that assure quality of OTC medicines, including manufacturing, product testing, expiration dating, etc. and training requirements for employees working in self-care/OTC medicines industries. Speakers: Jennifer Ahearn, Director of Regulatory and Compliance, Engineering Systems, Inc. John Punzi, Senior Director, Quality Assurance & Technical Affairs, CHPA |
| 11:15-11:30 a.m. | Closing Session |
| 11:30 a.m. | Session Adjourns |
Here are some highlights from the 2021 virtual self-paced Consumer Healthcare 101 course!
Our Expert Speakers
- Jennifer Ahearn, Senior Managing Consultant Pharmaceutical and Medical Devices, Esi
- Doug Bierer, Ph.D., President, Douglas Bierer Consulting, LLC
- Lisa Buono, Principal, Health Care Practice, IRI
- Edwin Hemwall, Ph.D., Principal, Edwin Hemwall LLC
- Marcia D. Howard, Ph.D., Vice President, Regulatory & Scientific Affairs, CHPA
- Barbara A Kochanowski, Ph.D., Senior Vice President, Regulatory & Scientific Affairs, CHPA
- Raqiyyah Pippins, Esq., Counsel, Arnold & Porter Kaye Scholer LLP
- John Punzi, Ph.D., Senior Director QA, and Technical Affairs, CHPA
- Jay Sirois, Ph.D., Senior Director, Regulatory & Scientific Affairs, CHPA
- David Spangler, Senior Vice President, Legal, Government Affairs & Policy, CHPA
Who should attend?
This course will be back in-person in 2022 and is open to all CHPA members. Non-members are also welcome to attend, please email Ushma J. Suvarnakar for registration information. Both entry-level and seasoned professionals are invited to attend from all industry job functions, including Business Development, Communications, Government, Legal, Marketing/Sales, Operations, Public Affairs, Quality, Regulatory, R&D, and Scientific.
$995.00 - Member Rate
Hotel and Travel
Baltimore Renaissance Harborplace Hotel
202 East Pratt Street
Baltimore, MD 21202
(410) 547-1200
- The CHPA 2022 CH101 Seminar Group Rate is $154.00.
- This discounted rate is available until 3:00 p.m. Thursday, March 17, 2022, or sooner if room block sells out.
Check-In and Check-Out
Check-in: 4:00 p.m.
Check-out: 12:00 p.m.
Cancellation Policy Cancellations must be received 48 hours prior to your arrival date to avoid a penalty fee of one night’s room and tax. Hotel Amenities Please visit the hotel website for a full list of amenities and features.
Travel Logistics Information
Airport
Baltimore/Washington International Thurgood Marshall Airport (BWI)
Train
Closest Amtrak Service is Baltimore Penn Station.
Ground Transportation
Taxis are readily available from BWI Airport and Baltimore Penn Train Station.
- $30-40 to/from Philadelphia International Airport
- $7-10 to/from Baltimore Penn Train Station
Travel time from Baltimore/Washington International Thurgood Marshall Airport (BWI) to Renaissance Baltimore Harborplace Hotel is approximately 20 minutes. Travel time from Baltimore Penn Station to Renaissance Baltimore Harborplace Hotel is approximately 10 minutes.
Understand the Consumer Healthcare Industry
New Upcoming Webinars
Engineered Self-Care Shapes a New Era for Consumer Health
January 27, 2022, at 2:00 p.m. EST
Learn how Engineered Self Care products will usher in a new era of Consumer Health.
Starting now and going forward, product development, including Rx to OTC Switch, and portfolio product improvement will include technology-powered and connected consumer support for safety, adherence, and appropriate use. In partnership with a credentialed and comprehensive Health Technology Platform, future-focused Consumer Health organizations can act now:
- Rx to OTC Switch: switch the drug and the technology-powered Quality process for safety, adherence, and appropriate use
- Unlock Restricted Ingredients: leverage technology capabilities to improve the retail experience and open e-commerce channels
- Connected Care: add data-driven, personalized digital companionship for longitudinal connections with brand consumers across the portfolio
With the right Health Technology Platform partner, Consumer Health companies will transform self-care – making it more effective, affordable, and consumer-friendly – and, in doing so, will reverse undertreatment and improve health equity.
This session will outline the attributes of a qualified Health Technology Platform partner and will demonstrate the consumer experience of Engineered Self-Care.
Webinar Objectives
- Learn about proven, technology-delivered, Quality processes now in the Rx domain that can be extended to support consumers in the nonprescription setting
- Learn how incorporating connected capabilities into product development can meet FDA requirements for Rx to OTC Switch Conditions of Safe Use and unlock other product improvement opportunities across the portfolio
- Explore actions that can be taken now to reverse undertreatment and improve health equity by making self-care a more accessible, effective, and longitudinal consumer experience
Environmental Sustainability: Wait, there's more ...
February 9, 2022, at 2:00 p.m. EST
Environmental sustainability issues are in the fore as societies and their governments think about climate change, as state legislators propose packaging or extended producer responsibility bills, and as shareholders demand action. Two experts from Covington & Burling, former EPA Administrator Carol Browner and former EPA General Counsel and White House advisory Gary Guzy, will provide their perspectives on how consumer healthcare companies of all shapes and sizes should think about approaches to environmental sustainability. Included will be: (1) A global review of evolving stakeholder interests and political dynamics. (2) How analogous industries are managing their sustainability goals. (3) Tips on navigating the intersections of FDA and EPA responsibilities.
Webinar Objectives
- Better understand the global and political context in the evolution of environmental sustainability demands.
- Learn about best practice approaches in developing sustainability goals, including from analogous industries.
- Gain insights on thinking about how to approach the intersection of FDA and EPA mandates and requirements.
FEP Sponsors
Sincere thanks to the following CHPA Associate members for supporting the platform launch as Founding Education Partners (FEP):
Register for CH101
CH101 2022 will be April 5-6 at the Baltimore Renaissance.